178 related articles for article (PubMed ID: 34900135)
21. Comprehensive Analysis of the Carcinogenic Process, Tumor Microenvironment, and Drug Response in HPV-Positive Cancers.
Yu X; Xu J; Xu D; Bi X; Wang H; Lu Y; Cao M; Wang W; Xu Z; Zheng D; Chen L; Zhang X; Zheng S; Li K
Front Oncol; 2022; 12():842060. PubMed ID: 35392231
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of virus infection and human cancer.
Chen CJ; Hsu WL; Yang HI; Lee MH; Chen HC; Chien YC; You SL
Recent Results Cancer Res; 2014; 193():11-32. PubMed ID: 24008291
[TBL] [Abstract][Full Text] [Related]
23. Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma.
Tian G; Fu Y; Zhang D; Li J; Zhang Z; Yang X
Cancer Cell Int; 2021 Mar; 21(1):167. PubMed ID: 33712015
[TBL] [Abstract][Full Text] [Related]
24. Implications of viral infections and oncogenesis in uterine cervical carcinoma etiology and pathogenesis.
Chu D; Liu T; Yao Y
Front Microbiol; 2023; 14():1194431. PubMed ID: 37293236
[TBL] [Abstract][Full Text] [Related]
25. All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
Kim HAJ; Zeng PYF; Shaikh MH; Mundi N; Ghasemi F; Di Gravio E; Khan H; MacNeil D; Khan MI; Patel K; Mendez A; Yoo J; Fung K; Lang P; Palma DA; Mymryk JS; Barrett JW; Boutros PC; Nichols AC
Oral Oncol; 2021 May; 116():105260. PubMed ID: 33725617
[TBL] [Abstract][Full Text] [Related]
26. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
Liu C; Guo T; Xu G; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Khan Z; Fisch KM; Califano J
Clin Cancer Res; 2018 Oct; 24(20):5123-5132. PubMed ID: 29945995
[No Abstract] [Full Text] [Related]
28. Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in Laryngeal, Oropharyngeal and Oral Cavity Cancer.
Drop B; Strycharz-Dudziak M; Kliszczewska E; Polz-Dacewicz M
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257122
[TBL] [Abstract][Full Text] [Related]
29. Pancancer Analysis of the Oncogenic and Prognostic Role of
Liu Q; Xie R; Li Y
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077008
[TBL] [Abstract][Full Text] [Related]
30. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
Zhang Z; Li L; Li M; Wang X
Comput Struct Biotechnol J; 2020; 18():2438-2444. PubMed ID: 32905022
[TBL] [Abstract][Full Text] [Related]
31. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
32. Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues.
Zhang J; Lu T; Lu S; Ma S; Han D; Zhang K; Xu C; Liu S; Gan L; Wu X; Yang F; Wen W; Qin W
Comput Struct Biotechnol J; 2023; 21():665-676. PubMed ID: 36659929
[TBL] [Abstract][Full Text] [Related]
33. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
34. Integration of scRNA-Seq and TCGA RNA-Seq to Analyze the Heterogeneity of HPV+ and HPV- Cervical Cancer Immune Cells and Establish Molecular Risk Models.
Wei E; Reisinger A; Li J; French LE; Clanner-Engelshofen B; Reinholz M
Front Oncol; 2022; 12():860900. PubMed ID: 35719936
[TBL] [Abstract][Full Text] [Related]
35. Genomic insights into head and neck cancer.
Beck TN; Golemis EA
Cancers Head Neck; 2016; 1():. PubMed ID: 29034103
[TBL] [Abstract][Full Text] [Related]
36. Viral Pathogens in Oesophageal and Gastric Cancer.
Rajendra K; Sharma P
Pathogens; 2022 Apr; 11(4):. PubMed ID: 35456151
[TBL] [Abstract][Full Text] [Related]
37. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
[TBL] [Abstract][Full Text] [Related]
38. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.
Wood O; Woo J; Seumois G; Savelyeva N; McCann KJ; Singh D; Jones T; Peel L; Breen MS; Ward M; Garrido Martin E; Sanchez-Elsner T; Thomas G; Vijayanand P; Woelk CH; King E; Ottensmeier C;
Oncotarget; 2016 Aug; 7(35):56781-56797. PubMed ID: 27462861
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
[TBL] [Abstract][Full Text] [Related]
40. HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region.
Bussu F; Sali M; Gallus R; Petrone G; Autorino R; Santangelo R; Pandolfini M; Miccichè F; Delogu G; Almadori G; Galli J; Sanguinetti M; Rindi G; Tommasino M; Valentini V; Paludetti G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S979-84. PubMed ID: 26286196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]